Research and Development

Driving Innovation. Delivering Global Healthcare Solutions.

“At GJC Pharmaceuticals Pvt Ltd, research is not just a function—it is our foundation. Our commitment to innovation empowers us to develop high-quality, globally compliant pharmaceutical solutions that improve patient outcomes and advance healthcare worldwide.”

Why Research Matters

Research and Development is the cornerstone of the pharmaceutical industry, transforming scientific discoveries into life-saving medicines. At GJC Pharmaceuticals, we continuously invest in innovation to stay ahead in an increasingly competitive and regulated global market.

Key Facts About Pharmaceutical R&D

• The average cost of developing a new medicine exceeds £550 million, with approximately 60% invested in clinical trials
• The complete drug development lifecycle typically spans 10–12 years
• Only 1–2 compounds out of 10,000 successfully reach market authorization
• Drug candidates may be discontinued at any stage due to safety, efficacy, or quality considerations

Our Commitment to Innovation

GJC Pharmaceuticals Pvt Ltd invests over 25% of its annual turnover into Research & Development—significantly higher than the industry average of 17%. This strong investment reflects our long-term vision to:

• Develop differentiated and high-value formulations
• Accelerate time-to-market for global launches
• Strengthen our position in regulated and semi-regulated markets

Our robust R&D pipeline is strategically designed to deliver innovative and commercially viable products, with multiple opportunities for global licensing and partnerships over the next decade.

Focus Therapeutic Areas

We prioritize research in therapeutic segments with high unmet medical needs, ensuring meaningful impact on patient care:

Cardiovascular Diseases : Diabetes & Metabolic Disorders: Osteoporosis & Bone Health: Hypertension & Heart Failure: Neuropsychiatric & Neurodegenerative Disorders: Oncology: Osteoarthritis

Our development strategy includes both new product innovation and lifecycle management of existing therapies, ensuring sustained portfolio growth.

Integrated Development & Manufacturing Strength

GJC Pharmaceuticals combines strong R&D capabilities with robust global manufacturing infrastructure, enabling seamless transition from development to commercialization.

Our Capabilities Include:

• Advanced solid oral dosage manufacturing (tablets, capsules, modified-release systems)
• Dedicated facilities for API and intermediate production
• Scalable processes aligned with WHO-GMP and international standards

This integration ensures: Faster product development cycles: Cost-effective manufacturing : Consistent product quality for global markets

Partner With GJC Pharmaceuticals

With a strong scientific foundation, global regulatory focus, and commitment to innovation, GJC Pharmaceuticals is your trusted partner for pharmaceutical research, development, and manufacturing excellence.

Let’s collaborate to bring innovative medicines to global markets.